ADIPOQ and polycystic ovary syndrome: demonstrated that a reduction in the expression of adiponectin receptors—AdipoR1 and AdipoR2—leads to an increased synthesis of androstenedione by ovarian theca cells, suggesting the involvement of adiponectin in the etiopathogenesis of hyperandrogenism in PCOS (28).